BioCentury
ARTICLE | Company News

Synthetic Biologics management update

February 3, 2014 8:00 AM UTC

Synthetic Biologics Inc. (NYSE-M:SYN), Rockville, Md. Business: Autoimmune, Neurology, Musculoskeletal Hired: Joseph Sliman as SVP of clinical and regulatory affairs, formerly senior medical director ...